Arthur K. Shapiro
|Arthur K. Shapiro|
Brooklyn, New York, United States
June 3, 1995 (aged 72)|
White Plains, New York
City College of New York (B.A.; 1951) |
University of Chicago (M.D.; 1955)
|Known for||Important contributions to the understanding of Tourette Syndrome|
Weill Cornell Medical College (1966–1977)|
Mount Sinai School of Medicine (1978–1995)
Arthur K. Shapiro, M.D., (1923–1995) was a psychiatrist and expert on Tourette syndrome. His "contributions to the understanding of Tourette syndrome completely changed the prevailing view of this disorder"; he has been described as "the father of modern tic disorder research" and is "revered by his colleagues as the first dean of modern Tourette syndrome researchers".
Contributions to Tourette syndrome research
Until the early 1970s, the preferred intervention for Tourette syndrome was psychoanalysis. Shapiro wanted to prove that Tourette's was an organic disorder, and that psychotherapy was not the treatment of choice. "The turning point in the diagnosis and treatment of Tourette Syndrome occurred in 1965", when Dr. Shapiro and his wife, Elaine Schlaffer Shapiro (Ph.D.), treated a patient with haloperidol (Haldol). The Shapiros reported the treatment in a 1968 article, published by the British Journal of Psychiatry, after it was rejected by American journals. The paper "severely criticized" the psychoanalytic approach, which had endured throughout the previous century, to treating the condition.
Working with the New York patient families who founded the Tourette Syndrome Association (TSA, since renamed to TAA) in 1972, the Shapiros advanced the argument that Tourette's was neurological rather than psychological, and the medical view of Tourette syndrome was "freed from its century-long submission to discredited psychoanalytic theory". In 1978, the Shapiros published a "landmark book" on the disorder, Gilles de la Tourette Syndrome. In 1981, Shapiro was chosen honorary co-president of the First International Tourette Syndrome Symposium, held in New York. Since the 1990s, a more neutral view of Tourette's is emerging as a condition involving an interaction between biological vulnerability and adverse environmental events.
A colleague, psychiatrist Ruth Bruun, described Arthur Shapiro as a revolutionary, "willing to challenge the prevailing dogma", "dynamic, charming, and relentlessly stubborn when fighting for what he thought was right", "an engaging speaker", and "a man of diverse interests and enthusiasm". Bruun also said, "It is extremely unusual for a couple of researchers to completely change the prevailing view of a disease, but this is exactly what they did."
Shapiro was born in Brooklyn, New York, and lived in Scarsdale, New York at the time of his death. He graduated in 1951 from City College of New York, obtained an MD in 1955 from the University of Chicago, was director of the Special Studies Laboratory at Cornell University until 1977, and was a physician at Mount Sinai School of Medicine.
After Arthur's death from lung cancer at the age of 72, Elaine published their last joint effort, The Powerful Placebo: From Ancient Priest to Modern Physician.
- Shapiro, Arthur K., Shapiro, Elaine, Gerald Young, J., et al. (January 1988). Gilles De La Tourette Syndrome. Raven Press Ltd; 2nd edition.
- Shapiro, Arthur K., Shapiro, Elaine (October 17, 2000). The Powerful Placebo : From Ancient Priest to Modern Physician. The Johns Hopkins University Press; New Ed edition.
- Shapiro AK, Shapiro E (1992). "Evaluation of the reported association of obsessive-compulsive symptoms or disorder with Tourette's disorder". Compr Psychiatry. 33 (3): 152–65. doi:10.1016/0010-440X(92)90024-K. PMID 1591906.
- Shapiro E, Shapiro AK, Fulop G, et al. (August 1989). "Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome". Arch. Gen. Psychiatry. 46 (8): 722–30. doi:10.1001/archpsyc.1989.01810080052006. PMID 2665687.
- Shapiro AK, Shapiro E, Fulop G (June 1987). "Pimozide treatment of tic and Tourette disorders". Pediatrics. 79 (6): 1032–9. PMID 3295739.
- Shapiro E, Shapiro AK (1982). "Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients". Adv Neurol. 35: 413. PMID 6959518.
- Cohen DJ, Jankovic J, Goetz CG, (eds). Advances in Neurology, Vol. 85, Tourette Syndrome. Lippincott, Williams & Wilkins, Philadelphia, PA, 2001., pp. xvii–xviii.
- Gadow KD, Sverd J. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate. Adv Neurol. 2006;99:197–207. PMID 16536367
- Leckman, JF. "A Cursing Brain? The Histories of Tourette Syndrome", Book review. The American Journal of Psychiatry October 1, 2001.
- Pagewise, Inc. Tourette syndrome. Archived February 8, 2005, at the Wayback Machine. Accessed 29 June 2006.
- Shapiro AK, Shapiro E (March 1968). "Treatment of Gilles de la Tourette's Syndrome with haloperidol". Br J Psychiatry. 114 (508): 345–50. doi:10.1192/bjp.114.508.345. PMID 4384341.
- Kushner, HI. A Cursing Brain? : The Histories of Tourette Syndrome. Harvard University Press, 2000, p. 194. ISBN 0-674-00386-1
- Black, KJ. Tourette Syndrome and Other Tic Disorders. eMedicine (March 22, 2006). Accessed 27 June 2006.
- Leckman JF, Cohen DJ."Tourette's Syndrome—Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care.". Archived from the original on 2005-03-03. Retrieved 2005-03-03. John Wiley & Sons, Inc., New York, 1999, p. vii.
- Saxon, Wolfgang (June 6, 1995). "Arthur Shapiro, 72; Led Research of Tourette's". New York Times. Retrieved 9 August 2009.